Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).
- DOI
- 10.1080/03009742.2016.1209550
- Published
- 2017 Sep
- Container
- Scandinavian journal of rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/03009742.2016.1209550,
title = {Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).},
author = {Møller-Bisgaard S and Ejbjerg BJ and Eshed I and Hørslev-Petersen K and Hetland ML and Jurik AG and Thomsen H and Torfing T and Stengaard-Pedersen K and Junker P and Krogh NS and Lottenburger T and Ellingsen T and Andersen LS and Skjødt H and Svendsen AJ and Tarp U and Hansen IT and Pødenphant J and Pedersen JK and Lindegaard H and Hanson LG and Vestergaard A and Glinatsi D and Østergaard M},
year = {2017},
journal = {Scandinavian journal of rheumatology},
doi = {10.1080/03009742.2016.1209550},
url = {https://doi.org/10.1080/03009742.2016.1209550}
}RIS
TY - JOUR TI - Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). AU - Møller-Bisgaard S AU - Ejbjerg BJ AU - Eshed I AU - Hørslev-Petersen K AU - Hetland ML AU - Jurik AG AU - Thomsen H AU - Torfing T AU - Stengaard-Pedersen K AU - Junker P AU - Krogh NS AU - Lottenburger T AU - Ellingsen T AU - Andersen LS AU - Skjødt H AU - Svendsen AJ AU - Tarp U AU - Hansen IT AU - Pødenphant J AU - Pedersen JK AU - Lindegaard H AU - Hanson LG AU - Vestergaard A AU - Glinatsi D AU - Østergaard M PY - 2017 JO - Scandinavian journal of rheumatology DO - 10.1080/03009742.2016.1209550 UR - https://doi.org/10.1080/03009742.2016.1209550 ER -
APA
S, M., BJ, E., I, E., K, H., ML, H., AG, J., H, T., T, T., K, S., P, J., NS, K., T, L., T, E., LS, A., H, S., AJ, S., U, T., IT, H., J, P., JK, P., H, L., LG, H., A, V., D, G., & M, Ø. (2017). Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).. Scandinavian journal of rheumatology. https://doi.org/10.1080/03009742.2016.1209550
Source records
- pubmed · retrieved 2026-09-25T06:12:17.926Z